ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 620462 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 620462; 2) Community: the network communities that were significantly associated with the response to NSC 620462; 3) Molecule: the relationships between components within communities and NSC 620462; 4) MDR: the compounds that were significantly associated with the NSC 620462.

NSC Compound Enrichment Correlation
NSC 735532 Null 0.049093561024907 0.10965834
NSC 756422 SB-236687 0.049093561024907 -0.021560685
NSC 135037 Jatrophone 0.0490935610249072 0.62730215
NSC 176507 Fastigilin C 3.8539705257259e-007 0.67886544
NSC 732837 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-4-chloro-3-trifluoromethylbenzene 5.49145982993963e-005 0.43486904
NSC 617826 Null 6.06965843704922e-006 0.67791031
NSC 86371 Quinolinium, 2-[2-(8-hydroxy-5-methyl-7-quinolyl)vinyl]-1,6-dimethyl- iodide 8.12512419150697e-005 0.36174824
NSC 112152 2H,4aH-1,4,5-Trioxadicyclopent[a,hi]indene-7-carboxylic acid, 3-ethylidene-3,3a,7a,9b-tetrahydro-2-oxo-, methyl ester, [3aS-(3E,3a.alpha.,4a.beta.,7a.beta.,9aR*,9b.beta.)]- (9CI) 9.15580043872279e-005 0.73552198
NSC 38643 Lenamycin 9.15580043872279e-005 0.54530036
Total:99  Current:99    [First] [Prev] [Next] [Last]